US FDA says commercial milk safe despite bird flu virus presence
Add details in paragraphs 4-9
By Manas Mishra and Jasper Ward
April 23 (Reuters) -The U.S. Food and Drug Administration said on Tuesday that it had found bird flu virus particles in some samples of pasteurized milk, but said commercial milk supply remains safe.
The FDA said that because the milk is pasteurized, it remains safe for human consumption as the process kills harmful bacteria and viruses by heating milk to a specific temperature.
"Based on available information, pasteurization is likely to inactivate the virus, however the process is not expected to remove the presence of viral particles," the FDA said.
The agency said it has been evaluating milk from affected animals, in the processing system and on the shelves. It said it is completing a large, representative national sample to understand the extent of the findings.
The FDA said it is further assessing any positive findings through egg inoculation tests, which it described as a gold standard for determining viable virus.
The agency said it has seen nothing that would change its assessment that the commercial milk supply is safe, adding that results from multiple studies will be made available in the next few days to weeks.
"Sound science is critical to informing public health decisions like those made by the FDA related to food safety and we take this current situation and the safety of the milk supply very seriously," the agency said.
There are confirmed cases of bird flu in dairy cattle in eight U.S. states, according to the U.S. Department of Agriculture.
The Centers for Disease Control and Prevention said one associated human case has been linked with the outbreak in dairy cows. The case was reported in Texas on April 1.
Reporting by Manas Mishra in Bengaluru and Jasper Ward in Washington; Editing by Shailesh Kuber
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
